معرفی
Katharina Mayer is a researcher at the Clinical Department of Nephrology and Dialysis at Medical University of Vienna. Her work focuses on therapeutic strategies for kidney transplant rejection.
- Affiliation: Clinical Department of Nephrology and Dialysis, Medical University of Vienna
- Key Research: Targeting CD38 to mitigate antibody-mediated rejection (AMR) in kidney transplants
Her research addresses the critical unmet clinical need for AMR therapies through innovative phase 2 trials using monoclonal antibodies. By analyzing molecular rejection transcripts and peripheral NK cell dynamics, her studies aim to establish novel treatment paradigms in transplant immunology.
Dr. Mayer's work contributes to precision medicine approaches in nephrology, with implications for improving long-term graft survival and understanding immune-mediated transplant injury mechanisms. Her clinical trial on felzartamab demonstrates safety profiles and measurable reductions in rejection biomarkers, positioning CD38 as a promising therapeutic target.
Katharina Mayer در سایتهای دیگر
جستوجوهای مرتبط
شاید اینها هم برایتان مناسب باشند
- AAbdolreza HaririanUniversity of Maryland, Baltimore · استاد
Katherine E. TwombleyMedical University of South Carolina · استاد- JJaap van den BornUniversity of Groningen · استاد
- MMarian van GroningenErasmus University Rotterdam · پژوهشگر
- AAnnelies de WeerdErasmus University Rotterdam · پژوهشگر
Stefan BergerUniversity of Groningen · استاد